{"id":"W3111069302","doi":"10.1007/s11523-020-00778-y","title":"Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA","year":2020,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"Merck Sharp and Dohme","keywords":"Medicine; Pembrolizumab; Nivolumab; Internal medicine; Population; Cohort; Retrospective cohort study; Oncology; Cancer; Immunotherapy; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008762259,0.0001944088,0.0003541076,0.00116693,0.0002977991,0.0008164354,0.0004496539,0.0004633782,0.0008139148],"category_scores_gemma":[0.003191153,0.0002271956,0.0006319414,0.002585478,0.0002317942,0.0005987692,0.0006582302,0.0005963038,0.0001340874],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001167654,"about_ca_system_score_gemma":0.0007284501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02527893,"about_ca_topic_score_gemma":0.0320619,"domain_scores_codex":[0.998674,0.0004435595,0.0002401962,0.0002468189,0.0002285381,0.0001668208],"domain_scores_gemma":[0.9961686,0.0004573001,0.002651097,0.00008829756,0.0002469069,0.0003878122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006189173,0.00002495837,0.9990589,0.000009512754,0.00006801699,0.00003458682,0.00004187493,0.00004809825,0.00002461886,0.0000133446,0.0001643899,0.0004498342],"study_design_scores_gemma":[0.000007090417,0.0000461599,0.9987204,0.00001343372,0.00003164585,0.0001532951,0.0003294983,0.0004042175,0.00002578643,0.00001497514,0.0002483465,0.000005117654],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972996,0.0002772087,0.00003711601,0.0001152656,0.000005041462,0.00001011342,0.002025235,0.000002204141,0.0002283168],"genre_scores_gemma":[0.9982625,0.0001677348,0.00006350965,0.00006779252,0.00001062283,0.00001674847,0.001373991,0.000001121402,0.0000361014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02527893,"threshold_uncertainty_score":0.05026358,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03138123723126232,"score_gpt":0.292119504055217,"score_spread":0.2607382668239546,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}